Alnylam Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$322.64(as of Jul 10, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Alnylam Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$322.64
Ticker SymbolALNY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees2,230
CountyUSA
Market Cap$41,837.6M
EBIDTA-57.8M
10-Day Moving Average323.61
P/E Ratio-155.13
20-Day Moving Average317.34
Forward P/E Ratio2,000.00
50-Day Moving Average296.86
Earnings per Share-2.09
200-Day Moving Average267.95
Profit Margin-9.67%
RSI58.73
Shares Outstanding130.39M
ATR9.36
52-Week High333.70
Volume474,983
52-Week Low205.87
Book Value115.4M
P/B Ratio362.44
Upper Keltner338.40
P/S Ratio17.82
Lower Keltner296.29
Debt-to-Equity Ratio338.40
Next Earnings Date07/30/2025
Cash Surplus-56.0M
Next Ex-Dividend DateUnknown
This innovative biotech stock has helped transform RNAi into an innovative new class of medicine. You have probably heard about RNA and mRNA innovation as the basis for the COVID-19 vaccine. This novel technology is set to shake up the medical world, and Alnylam is well-positioned to benefit from it.